Screener
Tempus AI, Inc. TEM Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| Clinical Order | $239.3M+31.8% | $245.9M+125% | $235.4M+124% | $221.7M+118% | $181.5M+94.3% | |
| Genomics Product | $21.8M+77.2% | —— | $252.9M+117% | $241.8M+115% | $12.3M-88.0% | |
| Insights Product | $71.3M+44.0% | $82M+26.7% | $69M+37.7% | $57.2M+40.5% | $49.5M+58.1% | |
| Next Product | $5.7M+111% | —— | —— | —— | $2.7M— | |
| Trials Product | $9.9M+2.1% | $9.8M-7.5% | $9.2M-8.9% | $9.8M-6.7% | $9.7M-14.2% |
FAQ
- How does Tempus AI, Inc. break its business down?
- Tempus AI, Inc. (TEM) reports revenue by product across 6 parts — AI Applications, Clinical Order, Genomics Product, Insights Product and Next Product. Each is extracted from the segment footnotes and tracked over time.
- Where does Tempus AI, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Tempus AI, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
